Wockhardt is currently trading at Rs. 560.45, up by 39.20 points or 7.52% from its previous closing of Rs. 521.25 on the BSE.
The scrip opened at Rs. 525.00 and has touched a high and low of Rs. 566.80 and Rs. 525.00 respectively. So far 320735 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1012.00 on 08-Jan-2018 and a 52 week low of Rs. 437.10 on 26-Oct-2018.
Last one week high and low of the scrip stood at Rs. 566.80 and Rs. 500.10 respectively. The current market cap of the company is Rs. 6195.66 crore.
The promoters holding in the company stood at 74.09%, while Institutions and Non-Institutions held 9.14% and 16.77% respectively.
Wockhardt has reported a fall of 79.86% in its net profit at Rs 5.10 crore for the quarter under review ended September 30, 2018 as compared to Rs 25.32 crore for the same quarter in the previous year. However, total income of the company increased by 6.95% at Rs 642.97 crore for Q2FY19 as compared Rs 601.16 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported net loss of Rs 22.77 crore for the quarter ended September 30, 2018 as compared to net loss of Rs 3.33 crore for the same quarter in the previous year. However, total consolidated income of the company increased by 5.10% at Rs 1,131.77 crore for Q2FY19 as compared Rs 1,076.83 crore for the corresponding quarter previous year.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1236.30 |
| Cipla | 1237.70 |
| Zydus Lifesciences | 943.20 |
| Lupin | 2331.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: